Atlas Trials

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

Clinical trial NCT05640024 · UNKNOWN

Trial details

NCT number
NCT05640024
Sponsor
Yonsei University
Status
UNKNOWN
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2022-11-06
Primary completion
2025-10-30
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.